Colon cancer cells treated with 5-fluorouracil exhibit changes in polylactosamine-type N-glycans
- 5 March 2014
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 9 (5) , 1697-1702
Abstract
5-Fluorouracil (5-FU) is the major chemotherapeutic agent for the treatment of colorectal carcinoma, which were found to have N-glycans containing polylactosamine on the cancer cell surface. Alterations in the expression and structure of polylactosamine glycans are associated with cellular differentiation and oncogenesis. However, little is known with regard to the correlation between the levels of polylactosamine expressed in colon cancer cells and the anticancer effect of 5-FU. In the present study, SW620 cells were treated with the half maximal inhibitory concentration (IC50; determined by MTT-assay) of 5-FU. Hoechst 33258 staining and flow cytometric analysis indicated that 5-FU administration resulted in apoptosis in SW620 cells. An increased percentage of cells in S phase was also observed among the SW620 cells treated with 5-FU. Under the same experimental conditions, a decrease in the 5-FU‑induced inhibition of polylactosamine glycans was recorded. However, an increase in the activity of alkaline phosphatase was also observed. Furthermore, pretreatment of the SW620 cells with 5-FU inhibited the expression of β1,3-N-acetylglucosaminyltransferase-8 (β3Gn-T8) and cluster of differentiation (CD)147 in a time-dependent manner. Overall, changes in glycosylation were associated with the anticancer effect of 5-FU in the colon cancer cells. In conclusion, polylactosamine may be a useful target for the identification of substances with anticancer activity.Keywords
This publication has 24 references indexed in Scilit:
- Suppression of Core 1 Gal-Transferase Is Associated with Reduction of TF and Reciprocal Increase of Tn, sialyl-Tn and Core 3 Glycans in Human Colon Cancer CellsPLOS ONE, 2013
- Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancerWorld Journal of Surgical Oncology, 2013
- N-glycosylation of Colorectal Cancer TissuesMolecular & Cellular Proteomics, 2012
- Synergistic Antitumor Effect of Dichloroacetate in Combination with 5‐Fluorouracil in Colorectal CancerBioMed Research International, 2011
- Activation of β1,3-N-Acetylglucosaminyltransferase-2 (β3Gn-T2) by β3Gn-T8Journal of Biological Chemistry, 2008
- Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activationProceedings of the National Academy of Sciences, 2007
- Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gainBritish Journal of Cancer, 2007
- A novel β1,3‐N‐acetylglucosaminyltransferase (β3Gn‐T8), which synthesizes poly‐N‐acetyllactosamine, is dramatically upregulated in colon cancerFEBS Letters, 2004
- Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: In vitro synergistic cytotoxicity and dna-induced strand-breaksEuropean Journal of Cancer, 1996
- Changes in glycosylation of L1210 cells after exposure to various antimetabolitesEuropean Journal of Cancer, 1993